Fred Hutchinson Cancer Research Center
EpiCypher Licenses Chromatin Profiling Technologies From Fred Hutchinson Cancer Center
The technologies, licensed co-exclusively, can be used to study histone post-translational modifications and chromatin-associated proteins.
Machine Learning Method Allows Highly Multiplexed Cell Surface Protein Analysis via Flow Cytometry
Premium
The method could offer a more accessible, less expensive way to measure the expression of hundreds of cell surface markers across millions of single cells.
Red Blood Cell Traits Linked to New Loci With Whole-Genome Sequencing Data
Using sequencing data for almost 62,700 individuals, researchers found new coding and non-coding variants associated with seven quantitative red blood cell features.
Since the commercial launch of its technology last year, the firm has been validating it in studies with academic groups and pharmaceutical companies.
Pediatric Brain Tumor Proteomics Highlight Possible Treatment Targets, Biomarkers
An integrated proteogenomic analysis led to previously unappreciated treatment targets or prognostic markers in craniopharyngioma, high-grade glioma, and other tumor types.